We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
+6.64%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$2.09B
AUM Growth
+$127M
Cap. Flow
+$96.6M
Cap. Flow %
4.63%
Top 10 Hldgs %
59.89%
Holding
266
New
179
Increased
23
Reduced
16
Closed
20

Top Sells

Rank Stock Value
1
AIFU
AIFU Inc
AIFU
+$83.3M
2
MOMO
Hello Group
MOMO
+$48.4M
3
VER
VEREIT, Inc.
VER
+$39.1M
4
BZUN
Baozun
BZUN
+$20.7M
5
CF icon
CF Industries
CF
+$16.6M

Sector Composition

Rank Sector Weight
1 Healthcare 44.37%
2 Financials 7.47%
3 Consumer Discretionary 4.86%
4 Communication Services 3.13%
5 Industrials 2.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
76
Procter & Gamble
PG
$340B
$2.05M 0.1%
+24,700
New +$2.02M
ORCL icon
77
Oracle
ORCL
$339B
$2M 0.1%
+38,655
New +$1.88M
BDX icon
78
Becton Dickinson
BDX
$46.4B
$1.98M 0.1%
7,811
+595
+8% +$147K
K
79
DELISTED
Kellanova
K
$1.98M 0.1%
+30,140
New +$2.03M
TLPH icon
80
Talphera
TLPH
$68M
$1.94M 0.09%
+23,952
New +$1.54M
BLK icon
81
Blackrock
BLK
$167B
$1.94M 0.09%
+4,050
New +$1.97M
VEON icon
82
VEON
VEON
$3.5B
$1.92M 0.09%
+26,424
New +$1.92M
DHR icon
83
Danaher
DHR
$138B
$1.92M 0.09%
+19,966
New +$1.82M
TMUS icon
84
T-Mobile US
TMUS
$195B
$1.9M 0.09%
+27,000
New +$1.73M
HD icon
85
Home Depot
HD
$337B
$1.88M 0.09%
9,100
-3,900
-30% -$785K
PLX icon
86
Protalix BioTherapeutics
PLX
$183M
$1.88M 0.09%
+263,140
New +$1.32M
UNH icon
87
UnitedHealth
UNH
$382B
$1.86M 0.09%
7,000
-5,100
-42% -$1.33M
JNJ icon
88
Johnson & Johnson
JNJ
$640B
$1.85M 0.09%
+13,400
New +$1.78M
SLB icon
89
SLB Ltd
SLB
$72.7B
$1.85M 0.09%
+30,200
New +$1.94M
LKQ icon
90
LKQ Corp
LKQ
$6.72B
$1.84M 0.09%
+58,000
New +$1.93M
KO icon
91
Coca-Cola
KO
$383B
$1.83M 0.09%
+39,700
New +$1.81M
OPK icon
92
Opko Health
OPK
$1.02B
$1.82M 0.09%
+553,142
New +$2.94M
EL icon
93
Estee Lauder
EL
$30.4B
$1.74M 0.08%
+12,100
New +$1.68M
IMGN
94
DELISTED
Immunogen Inc
IMGN
$1.72M 0.08%
+178,749
New +$1.72M
CCXI
95
DELISTED
ChemoCentryx, Inc.
CCXI
$1.72M 0.08%
+159,050
New +$1.92M
HDB icon
96
HDFC Bank
HDB
$123B
$1.71M 0.08%
73,280
+45,760
+166% +$1.17M
ECYT
97
DELISTED
Endocyte, Inc. Common Stock
ECYT
$1.62M 0.08%
+90,963
New +$1.56M
EXPE icon
98
Expedia Group
EXPE
$36.5B
$1.59M 0.08%
+12,100
New +$1.57M
NVDA icon
99
NVIDIA
NVDA
$4.6T
$1.57M 0.08%
235,600
-11,200
-5% -$72.8K
IMMU
100
DELISTED
Immunomedics Inc
IMMU
$1.56M 0.07%
+75,433
New +$1.79M

Similar funds

Fosun International's Q3 2018 Portfolio in Review

As of Q3 2018, Fosun International held 266 positions worth $2.09B, up 6.5% from $1.96B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Fosun International deployed $96.6M of net new capital in Q3 2018, opening 179 new positions and adding to 23 existing holdings. Its largest new stake was BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares: 331,701 shares worth $39.3M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Amneal Pharmaceuticals, an estimated $15.6M trimmed.

  • Fosun International's largest Q3 2018 buy was BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares: 331,701 shares worth $39.3M.
  • Fosun International added most to ViewRay, Inc. in Q3 2018, an estimated $26.6M increase.
  • Fosun International's biggest Q3 2018 reduction was Amneal Pharmaceuticals, cutting an estimated $15.6M.
  • Fosun International fully exited AIFU Inc in Q3 2018, selling an estimated $83.3M.
  • Fosun International's ten largest holdings make up 60% of its $2.09B portfolio in Q3 2018.
  • Fosun International opened 179 new positions and closed 20 in Q3 2018.
  • Fosun International's portfolio value rose 6.5% quarter-over-quarter to $2.09B.

Based on Fosun International's 13F filing for Q3 2018, filed 9 Nov 2018.